Limitations, agreements, and source contact

DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma · Source last updated 2026-10-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

GT60

restrictive Agreement

true

point Of Contact

email

yuexie@ds.dfci.harvard.edu

organization

PrECOG

phone

404-229-7622

title

Yue Xie, MS

Download exact source JSON → · Snapshot ctgov-results-d643ffaf417bcef6d45eb5e0

Preserved source evidence · Not medical advice